Importantly, high activity of the AMPK-PDH axis, indicated by high p-AMPK (T172) levels and low p-PDHA (S293) levels, correlated with poor metastasis-free survival in breast cancer patients, highlighting the clinical value of the AMPK-PDH cascade in the prediction of metastatic outcome. Here, PDHA1 is linked to breast cancer.